Efficacy and safety of sitagliptin added to ongoing metformin and pioglitazone combination therapy in a randomized, placebo-controlled, 26-week trial in patients with type 2 diabetes

✍ Scribed by Fonseca, Vivian; Staels, Bart; Morgan, Jerry D.; Shentu, Yue; Golm, Gregory T.; Johnson-Levonas, Amy O.; Kaufman, Keith D.; Goldstein, Barry J.; Steinberg, Helmut

• Book ID: 122634589
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 536 KB
• Volume: 27
• Category: Article
• ISSN: 1056-8727
• DOI: 10.1016/j.jdiacomp.2012.09.007